Condition: Coronary Arterial Disease (CAD) · Angina (Stable) · Microvascular Circulation · Sponsor: VZW Cardiovascular Research Center Aalst
The goal of this clinical trial is to learn whether beta-blockers can improve coronary blood flow and reduce resistance in patients with angina and no obstructive coronary arteries (ANOCA). The main questions it aims to answer are: * Do beta-blockers improve coronary blood flow in patients with ANOCA? * Do beta-blockers reduce coronary microvascular resistance in these patients? Researchers will compare a beta-blocker to a placebo to see if the medication has measurable effects on coronary circulation. Participants will: * Receive a beta-blocker or a placebo * Undergo specialized heart tests (such as coronary flow and resistance measurements) before and after treatment.
This description comes directly from the study's public registry record.
Adriaan Wilgenhof, MD · +32 53 72 44 39 · adriaan.wilgenhof@azorg.be
Thabo Mahendiran, MD · thabo.mahendiran@doctors.org.uk
Always discuss trial participation with your own doctor first.
| OLV Cardiovascular Center Aalst | Aalst, Flanders, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06864234